Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 161Lymphoid 121Other hematologic neoplasm 73Myeloid 16Genitourinary 12Classical hematology 7Dermatologic 5Sarcoma 3Gastrointestinal 3Head & Neck 2Endocrine 2CNS 2Tumor-Agnostic 1Thoracic 1NET 1Gynecologic 1

Conditions

Pancreatic Neoplasms 1Liver Neoplasms 1Colorectal Neoplasms 1

Interventions

Fluorouracil 286Oxaliplatin 274Gemcitabine 222Capecitabine 221Leucovorin 219Bevacizumab 200Irinotecan 170pembrolizumab 140Cisplatin 132Cetuximab 111Radiotherapy 109Sorafenib 75Nivolumab 74130-nm albumin-bound paclitaxel 64Albumin-Bound Paclitaxel 63Paclitaxel 62Docetaxel 61Erlotinib Hydrochloride 57Panitumumab 56Radiosurgery 47Folfox protocol 46regorafenib 45Sunitinib 40Radiation 39Magnetic Resonance Spectroscopy 37durvalumab 33Surgical Procedures, Operative 33Trastuzumab 32Ramucirumab 32Cyclophosphamide 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Lenalidomide × Gastrointestinal × Clear all
NCT00717756 2020-02-17

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

Brown University

Phase 2 Completed
41 enrolled 6 charts
Gastrointestinal

Liver Neoplasms

NCT01032291 2013-05-21

A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer

Celgene

Phase 2 Terminated
51 enrolled 12 charts
Gastrointestinal

Colorectal Neoplasms

NCT00837031 2013-03-13

Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas

SCRI Development Innovations, LLC

Phase 2 Completed
72 enrolled 7 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡